XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ DEFICIT (Tables)
9 Months Ended
Sep. 30, 2022
Equity [Abstract]  
SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

 

Exercise price  $1.21 
Expected dividend yield   0%
Risk free interest rate   1.73%
Expected life in years   10 
Expected volatility   146%
SCHEDULE OF SHARE-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following is an analysis of the stock option grant activity under the Plan:

 

      

Weighted

Average

  

Weighted

Average

 
   Number   Exercise Price   Remaining Life 
Stock Options               
                
Outstanding December 31, 2021   5,520,861   $1.84    6.32 
Granted   50,000   $1.21    9.27 
Expired   (66,000)  $2.12    - 
Exercised   -   $-    - 
Outstanding September 30, 2022   5,504,861   $1.84    5.66 
SCHEDULE OF SHARE-BASED COMPENSATION NONVESTED SHARES

A summary of the status of the Company’s nonvested options as of September 30, 2022, and changes during the nine months ended September 30, 2022, is presented below:

 

Nonvested Options  Options  

Weighted-

Average

Exercise Price

 
Nonvested at December 31, 2021   810,333   $3.08 
Granted   50,000   $1.21 
Vested   (274,895)  $1.57 
Forfeited   -   $- 
Nonvested at September 30, 2022   585,438   $3.11 
SUMMARY OF WARRANT ISSUANCES

A summary of warrant issuances are as follows:

 

      

Weighted

Average

  

Weighted

Average

 
   Number   Exercise Price   Remaining Life 
Warrants               
                
Outstanding December 31, 2021   6,132,630   $3.38    3.15 
Granted   16,000    1.25    4.27 
Expired   -    -    - 
Exercised   -    -    - 
Outstanding September 30, 2022   6,148,630   $3.37    2.40